Effectiveness of Nutritional Products to Treat Moderate Acute Malnutrition

The purpose of this study is to determine whether an improved corn-soya blend (CSB+) and a new formulated ready-to-use supplementary food (RUSF) are effective in the treatment of moderate acute malnutrition in children.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Wasting Body Weight Body Weight Changes Cachexia Moderate Acute Malnutrition Pathological Conditions, Signs and Symptoms Signs and Symptoms Thinness Weight Loss

Age range

6 month–59 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Biyem Assi District Centre, Yaoundé, Cameroon

About this study

Assuming the availability of some food in the household, the caregivers were instructed on how best to use the food they have and the quantity of supplementary food distributed was calculated to provide about 50% of child energy requirement.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Children aged 6-59 month
Weight-for-height between -3 and -2 z-scores without edema
Good appetite
Stable clinical conditions

Exclusion criteria

Weight-for-Height Z-score < -3
Presence of bilateral pitting edema
Unstable clinical conditions
Not showing appetite

Treatment and study plan

A daily ration of 40 kcal/kg of body weight during 56 days

Dietary Supplement

On enrollment, children were examined by a pediatrician to assess their health status and they were de-wormed with one tablet of Mebendazole 500 mg.

Primary outcomes

Recovery rate of the children receiving CSB+ or RUSF

Time frame: 56 days

Children with Weight-for-Height Z-score > -2

Sponsors and collaborators

Lead sponsor

Centre for Food and Nutrition Research, Yaounde

Other Gov

Collaborators

International Atomic Energy Agency

Registry information

Official study title

Using Indigenous Foods to Reduce Malnutrition in Children

Important dates

Study start: 2012
Primary completion: 2012
Study completion: 2012
First posted: Jul 12, 2013
Registry last updated: Jul 12, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed